Research Fellow in Medicine, Massachusetts General Hospital
Cardiology
Dr. Steven A. Lubitz, MD
|
|
Give Review
Steven Lubitz practices Cardiology. He studied medicine at Mount Sinai School of Medicine. Steven Lubitz has written publications. He has 76 publications published with PubMed. The lastest publication is: 'Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.' Steven A. Lubitz, MD accepts all Medicare patients.
Publications
- Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis ...
- Atrial Flutter - Clinical Risk Factors and Adverse Outcomes in the Framingham Heart Study.
- Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly.
- Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
- Somatic mutations and Atrial fibrillation: the end or just the beginning?
- Next-generation sequencing for the diagnosis of cardiac arrhythmia Syndromes.
- Increased Perforation Risk with an MRI-Conditional Pacing Lead: A Single-Center Study.
- Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future Atrial fibrillation and stroke.
- Biventricular pacing: more is better!
- B-type natriuretic peptide and C-reactive protein in the prediction of Atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
- Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Targeted sequencing in candidate genes for Atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study.
- Warfarin pharmacogenetics: A controlled dose-response study in healthy subjects.
- Stroke Prevention in Atrial Fibrillation in Older Adults: Existing Knowledge Gaps and Areas for Innovation: A Summary of an American Federation for Aging Research Semi...
- Genetic etiology and evaluation of sudden cardiac death.
- Reciprocal relations between physical disability, subjective health, and Atrial fibrillation: The Framingham Heart Study.
- Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
- Risk assessment for incident heart failure in individuals with Atrial fibrillation.
- Genomic risk scores in Atrial fibrillation: predicting the unpredictable?
- Common genetic variation near the connexin-43 gene is associated with resting Heart rate in African Americans: A genome-wide association study of 13,372 participants.
- Genetic susceptibility to Atrial fibrillation: does heart failure change our perspective?
- Low serum magnesium and the development of Atrial fibrillation in the community: the Framingham Heart Study.
- Meta-analysis identifies six new susceptibility loci for Atrial fibrillation.
- Plasma resistin, adiponectin, and risk of incident Atrial fibrillation: The Framingham Offspring Study.
- Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU.
- White Blood Cell Count and Risk of Incident Atrial Fibrillation (From the Framingham Heart Study).
- Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
- Genetic variation in the alternative splicing regulator RBM20 is associated with dilated Cardiomyopathy.
- Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study).
- Vitamin D status is not related to development of Atrial fibrillation in the community.
- Large-Scale Candidate Gene Analysis in Whites and African-Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation: The NHLBI CARe Project.
- Elevation of parathyroid hormone levels in Atrial fibrillation.
- Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
- A novel clinical prediction rule for 30-day mortality following balloon Aortic valuloplasty: the CRRAC the AV score.
- P wave duration and risk of longitudinal Atrial fibrillation in Persons ≥ 60 years old (from the Framingham Heart Study).
- Lack of replication in polymorphisms reported to be associated with Atrial fibrillation.
- A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with Atrial fibrillation.
- Dietary factors and incident Atrial fibrillation: the Framingham Heart Study.
- Association between familial Atrial fibrillation and risk of new-onset Atrial fibrillation.
- P-wave indices: derivation of reference values from the Framingham Heart Study.
- Independent susceptibility markers for Atrial fibrillation on chromosome 4q25.
- Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice.
- Genetics of Atrial fibrillation: implications for future research directions and personalized medicine.
- Atrial fibrillation in congestive heart failure.
- Common variants in KCNN3 are associated with lone Atrial fibrillation.
- Genome-wide association study of PR interval.
- Variants in ZFHX3 are associated with Atrial fibrillation in individuals of European ancestry.
- Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.
- Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.
- Dobutamine-induced myocardial infarction with normal Coronary arteries during stress SPECT myocardial perfusion imaging.
- Statin therapy associated with a reduced risk of Chronic renal failure after cardiac transplantation.
- Long-term results of tacrolimus monotherapy in cardiac transplant recipients.
- Early reactions to Harvey's circulation theory: the impact on medicine.
- Blood lipids and the incidence of Atrial fibrillation: the multi-ethnic study of atherosclerosis and the framingham heart study.
- Whole blood gene expression and Atrial fibrillation: the framingham heart study.
- Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community.
- Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
- Can initial tacrolimus trough levels be predicted from clinical variables?
- Improved survival with statins, angiotensin receptor blockers, and steroid weaning after Heart transplantation.
- Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population.
- Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers.
- Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation.
- Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
- A promising technique for treating circulatory arrest associated coagulopathy.
- Catheter ablation for Atrial fibrillation.
- CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
- Evaluation of non-synonymous NPPA single nucleotide polymorphisms in Atrial fibrillation.
- Effectiveness of cardiac resynchronization therapy in mild congestive Heart failure: systematic review and meta-analysis of randomized trials.
- Stroke risk in AF: do AF patterns matter?
- Challenges in the classification of Atrial fibrillation.
- European ancestry as a risk factor for Atrial fibrillation in African Americans.
- Monogenic Atrial fibrillation as pathophysiological paradigms.
- Genome-wide association studies of the PR interval in African Americans.
- Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.
Schools
University of Mi Med Sch
Mount Sinai Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Mount Sinai School of Medicine -
University of Michigan Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1154589422 | |
| NPPES Provider LastName | LUBITZ | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154589422 |
| Last Name Of The Provider | LUBITZ |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Piotr S. Sobieszczyk, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
John A. O'Dea, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roy Beinart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Begona Benito Villabriga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher P. Cannon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brendan M. Everett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katie M. Hawthorne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew C. Eisenhauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Igor F. Palacios, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khalid S. Aljabri, MD |